GSK Surges After Settling First Zantac Case, But A ' Conveyor Belt ' Of Claims Looms

GSK stock jumped Friday after the British drugmaker said it settled one of thousands of claims that its heartburn drug Zantac caused cancer. The post GSK Surges After Settling First Zantac Case, But A 'Conveyor Belt' Of Claims Looms appeared first on Investor's Business Daily.#gsk #conveyorbelt
Source: Reuters: Health - Category: Consumer Health News Source Type: news